Esber Henry Jemil

EVP Pre-Clinical Business Dev., DirectorNEXMED INC (NEXM) · full profile →Form 4 · filed Mar 17, 2010
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 15, 2010Grant(A)1.4M$0.17$245K2.1M
Mar 15, 2010Grant(A)739K$0.17$126K1.1M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001144204-10-014029) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.